1. Home
  2. CAVA vs MMSI Comparison

CAVA vs MMSI Comparison

Compare CAVA & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CAVA Group Inc.

CAVA

CAVA Group Inc.

HOLD

Current Price

$48.97

Market Cap

5.8B

ML Signal

HOLD

MMSI

Merit Medical Systems Inc.

HOLD

Current Price

$86.88

Market Cap

4.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAVA
MMSI
Founded
2006
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
4.8B
IPO Year
2023
1990

Fundamental Metrics

Financial Performance
Metric
CAVA
MMSI
Price
$48.97
$86.88
Analyst Decision
Buy
Strong Buy
Analyst Count
18
8
Target Price
$79.56
$105.38
AVG Volume (30 Days)
5.1M
707.6K
Earning Date
11-04-2025
10-30-2025
Dividend Yield
N/A
N/A
EPS Growth
151.16
N/A
EPS
1.16
1.95
Revenue
$1,132,074,000.00
$1,477,128,000.00
Revenue This Year
$24.73
$13.38
Revenue Next Year
$21.88
$6.50
P/E Ratio
$42.17
$44.80
Revenue Growth
23.93
11.41
52 Week Low
$43.41
$78.12
52 Week High
$153.34
$111.45

Technical Indicators

Market Signals
Indicator
CAVA
MMSI
Relative Strength Index (RSI) 43.25 53.89
Support Level $46.26 $82.70
Resistance Level $51.15 $88.57
Average True Range (ATR) 2.47 2.41
MACD 0.81 -0.00
Stochastic Oscillator 72.74 68.75

Price Performance

Historical Comparison
CAVA
MMSI

About CAVA CAVA Group Inc.

Cava Group Inc owns and operates a chain of restaurants. It is the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. The company's dips, spreads, and dressings are centrally produced and sold in grocery stores. The company's operations are conducted as two reportable segments: CAVA and Zoes Kitchen. The company generates all of its revenue from the CAVA segment.

About MMSI Merit Medical Systems Inc.

Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.

Share on Social Networks: